A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results.Anthony W. Tolcher, Patricia LoRusso, Benedito A. Carneiro et al.|Journal of Clinical Oncology|2021Cited by 33
Preliminary Phase 1 Results of the PD-1 Inhibitor ABBV-181 in Japanese vs Western Patients With Advanced Solid TumorsYasutoshi Kuboki, Noboru Yamamoto, Afar Daniel et al.|Annals of Oncology|2019Cited by 1
Contents Vol. 60, 2014Michael H. Schwenk, Satz Mengensatzproduktion, Klaus Hauer et al.|Gerontology|2014Cited by 0